Review and comparison the success rate, using medroxy progesterone acetate instead of GNRH antagonist,in patients undergoing intracytoplasmic sperm injection (ICSI) by using oocyte donatio
Phase 3
- Conditions
- Infertility in female.N97.0Female infertility associated with anovulation
- Registration Number
- IRCT20081007001306N10
- Lead Sponsor
- Research vice-chancellorship, Guilan University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 216
Inclusion Criteria
All infertile patients with oocyte donation undergoing ICSI
Exclusion Criteria
In the oocyte donor:Age over 35 years, irregular menstruation, antral follicle count less than 5 and more than 12, FSH more than 10 on the third day of menstruation, cystic ovaries and endometriosis, BMI greater than 25, not having at least one child and the presence of any disease affecting ovulation (such as thyroid disease and high prolactin levels)
In the oocyte receptor: Age over 50 years , any systemic disease including hypertension, diabetes, chronic diseases, liver and kidney, problem in the uterus and tubes (including: leiomyoma, polyp, adenomyosis, ashren and hydrosalpinx and etc.) and there is male factor
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Fertility success. Timepoint: Two weeks after fetal transfer. Method of measurement: Pregnancy test.
- Secondary Outcome Measures
Name Time Method Seeing fetal heart rate. Timepoint: 6 weeks after fetal transfer. Method of measurement: Vaginal ultrasound.